Amyloid-β is NOT only the most promising target for Alzheimer’s disease

Amyloid-β is NOT only the most promising target for Alzheimer’s disease

Saved in:

Bibliographic Details
Main Authors:	Beka Solomon, Milana Voronov-Goldman
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2026-02-01
Series:	Neural Regeneration Research
Online Access:	https://journals.lww.com/10.4103/NRR.NRR-D-24-00829
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Targeting Amyloid Pathology in Early Alzheimer’s: The Promise of Donanemab-Azbt
by: Nadia Khartabil, et al.
Published: (2025-02-01)

β-Amyloids and Immune Responses Associated with Alzheimer’s Disease
by: Elizaveta Kolobova, et al.
Published: (2024-09-01)

Trans-Synaptic Spread of Amyloid-β in Alzheimer’s Disease: Paths to β-Amyloidosis
by: Annabella Pignataro, et al.
Published: (2017-01-01)

Numerical Investigation of β-Amyloid Aggregation Process In Alzheimer’s Disease
by: Wibowo Zefanya Putri Rida, et al.
Published: (2025-01-01)

Phototherapy via Modulation of β‐Amyloid in Combating Alzheimer's Disease
by: Yunhua Zhang, et al.
Published: (2025-05-01)

Nanomaterials in targeting amyloid-β oligomers: current advances and future directions for Alzheimer's disease diagnosis and therapy
by: Shiwani Randhawa, et al.
Published: (2025-04-01)

Neuroprotective potential of quercetin in Alzheimer’s disease: targeting oxidative stress, mitochondrial dysfunction, and amyloid-β aggregation
by: Mohd Adnan, et al.
Published: (2025-06-01)

Amyloid-β Inhibiting Peptides: An Innovative Strategy for Alzheimer’s Disease Treatment
by: Sajjad Molavipordanjani, et al.
Published: (2023-11-01)

The link between amyloid β and ferroptosis pathway in Alzheimer’s disease progression
by: Naďa Majerníková, et al.
Published: (2024-10-01)

Synthetic Peptide Corresponding to The Amino-Terminal Region of the Human Tryptophanyl-Trna Synthetase, a Component Of Alzheimer’S Disease Special Congophlic Plaques Aggregates In Vitro to Form Amyloid-Like Fibrils
by: Elena L. Paley, et al.
Published: (2002-01-01)

Nose-to-brain delivery of targeted lipid nanoparticles as two-pronged β-amyloid nanoscavenger for Alzheimer's disease therapy
by: Yanyan Xu, et al.
Published: (2025-06-01)

N-Alkylamino Stilbene Compounds as Amyloid β Inhibitors for Alzheimer’s Disease Research
by: Citlali Gutiérrez, et al.
Published: (2025-06-01)

Anti-amyloid β hydrophobic peptides in Alzheimer’s disease: biomarkers and therapeutic potential
by: Carlos Gutierrez-Merino
Published: (2025-02-01)

Recent advances in immunotherapy targeting amyloid-beta and tauopathies in Alzheimer’s disease
by: Sha Sha, et al.
Published: (2026-02-01)

Diagnostic Challenge in Frontal Variant Alzheimer's Disease With Low Amyloid‐β PET Retention
by: Ryosuke Shimasaki, et al.
Published: (2025-07-01)

Moderate‐ to high‐intensity exercise does not modify cortical β‐amyloid in Alzheimer's disease
by: Kristian S. Frederiksen, et al.
Published: (2019-01-01)

Mannose Promotes β‐Amyloid Pathology by Regulating BACE1 Glycosylation in Alzheimer's Disease
by: Chensi Liang, et al.
Published: (2025-03-01)

Unraveling the complex role of microglia in Alzheimer’s disease: amyloid β metabolism and plaque formation
by: Sho Takatori, et al.
Published: (2025-05-01)

Role of neuronal fabp in autophagy and amyloid-β pathology in a Drosophila model of Alzheimer disease
by: Byoungyun Choi, et al.
Published: (2025-12-01)

The impact of kidney function on Alzheimer’s disease blood biomarkers: implications for predicting amyloid-β positivity
by: Burak Arslan, et al.
Published: (2025-02-01)

miR‐32533 Reduces Cognitive Impairment and Amyloid‐β Overload by Targeting CREB5‐Mediated Signaling Pathways in Alzheimer's Disease
by: Li Zeng, et al.
Published: (2025-03-01)

Alzheimer's-related peptide amyloid-β plays a conserved role in angiogenesis.
by: D Joshua Cameron, et al.
Published: (2012-01-01)

New insights into the 17β-hydroxysteroid dehydrogenase type 10 and amyloid-β 42 derived cytotoxicity relevant to Alzheimer’s disease
by: Aneta Houfková, et al.
Published: (2025-07-01)

Targeting Iron Responsive Elements (IREs) of APP mRNA into Novel Therapeutics to Control the Translation of Amyloid-β Precursor Protein in Alzheimer’s Disease
by: Mateen A. Khan
Published: (2024-12-01)

Development of a Japanese polygenic risk score model for amyloid-β PET imaging in Alzheimer’s disease
by: Misato Kaishima, et al.
Published: (2025-05-01)

Reevaluating the role of amyloid β-peptides in Alzheimer’s disease: from pathogenic agents to protective chelation mechanisms
by: Franco Cavaleri
Published: (2025-03-01)

Computational discovery of plant-derived flavonoids as potential amyloid-β fibril disaggregating agents for alzheimer’s disease
by: Uthirapathi Logeswari Rakesh, et al.
Published: (2025-06-01)

Photoelectrochemical immunosensing of amyloid-β peptide using nanoplasmonic macroporous bismuth vanadate for Alzheimer's disease diagnosis
by: Wenting Chen, et al.
Published: (2025-06-01)

Beneficial effect of antibodies against β- secretase cleavage site of APP on Alzheimer's-like pathology in triple-transgenic mice.
by: Inna Rabinovich-Nikitin, et al.
Published: (2012-01-01)

Understanding the impact of amyloid beta targeted therapies on biomarkers and clinical endpoints in Alzheimer's disease
by: Ronald C. Petersen, et al.
Published: (2025-04-01)

The amyloid hypothesis of Alzheimer's disease at 25 years
by: Dennis J Selkoe, et al.
Published: (2016-03-01)

Amyloid blood biomarker detects Alzheimer's disease
by: Andreas Nabers, et al.
Published: (2018-04-01)

Microglial cGAS Deletion Preserves Intercellular Communication and Alleviates Amyloid‐β‐Induced Pathogenesis of Alzheimer's Disease
by: Sijia He, et al.
Published: (2025-03-01)

Compensatory enhancement of orexinergic system functionality induced by amyloid-β protein: a neuroprotective response in Alzheimer’s disease
by: Chenyu Zhuang, et al.
Published: (2025-03-01)

Aerobic exercise improves clearance of amyloid-β via the glymphatic system in a mouse model of Alzheimer's Disease
by: Shengxiang Liang, et al.
Published: (2025-03-01)

Nasal Aβ42 mirrors brain amyloid dynamics and cognitive decline across the Alzheimer’s disease continuum
by: Da Hae Jung, et al.
Published: (2025-08-01)

Diamagnetic Signature of Beta‐Amyloid (Aβ) and Tau (τ) Tangle Pathology in Alzheimer's Disease: A Review
by: Sadegh Ghaderi, et al.
Published: (2025-02-01)

An Overview of Glutaminyl Cyclase as a Promising Drug Target for Alzheimer’s Disease
by: Rasajna Madhusudhana, et al.
Published: (2025-06-01)

Novel Alzheimer risk genes determine the microglia response to amyloid‐β but not to TAU pathology
by: Annerieke Sierksma, et al.
Published: (2020-01-01)

Brain p3‐Alcβ peptide restores neuronal viability impaired by Alzheimer's amyloid β‐peptide
by: Saori Hata, et al.
Published: (2023-03-01)